Form 8-K - Current report:
SEC Accession No. 0000950170-23-032449
Filing Date
2023-07-11
Accepted
2023-07-11 08:32:08
Documents
14
Period of Report
2023-07-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acet-20230710.htm   iXBRL 8-K 58730
2 EX-99.1 acet-ex99_1.htm EX-99.1 17576
3 GRAPHIC img94724212_0.jpg GRAPHIC 2032
  Complete submission text file 0000950170-23-032449.txt   206083

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT acet-20230710_pre.xml EX-101.PRE 10289
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT acet-20230710_lab.xml EX-101.LAB 14018
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT acet-20230710.xsd EX-101.SCH 2472
8 EXTRACTED XBRL INSTANCE DOCUMENT acet-20230710_htm.xml XML 4933
Mailing Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 19TH FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 231081255
SIC: 2834 Pharmaceutical Preparations